Scientists are rapidly focused on retatrutide, a novel drug created by Eli Lilly, as a possible step in weight loss . Different than many previous approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, hormones that affect satiety and blood glucose control . Initial pati… Read More